GC-373

N/A

Report date: 2024/12/10 15:07:36
NME

Base Information

Drug NameGC-373
Drug Alias NameGC-373
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSARS-CoV-2-3C-like-proteinase inhibitors
TargetsSARS-CoV-2-3C-like-proteinase
Therapy Area/IndicationsCaliciviridae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWichita State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWichita State University
Active IndicationsN/A
Inactive IndicationsCaliciviridae Infections

Other Information

ATC CodeN/A
Related LinksN/A